1 |
Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003;278:34387-94.
DOI
|
2 |
Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 2004;229:293-309.
DOI
ScienceOn
|
3 |
Blair HC, Zaidi M, Schlesinger PH. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 2002;364:329-41.
DOI
ScienceOn
|
4 |
Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002;2:389-406.
DOI
ScienceOn
|
5 |
Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-8.
DOI
ScienceOn
|
6 |
Hedvat CV, Yao J, Sokolic RA, Nimer SD. Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem 2004;279:6395-400.
DOI
|
7 |
Towler DA, Rutledge SJ, Rodan GA. Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 1994;8:1484-93.
DOI
ScienceOn
|
8 |
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64.
DOI
ScienceOn
|
9 |
Olsen BR, Reginato AM, Wang W. Bone development. Ann Rev Cell Dev Biol 2000;16:191-220.
DOI
ScienceOn
|
10 |
Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423:349-355.
DOI
ScienceOn
|
11 |
Wai PY, Mi Z, Gao C, Guo H, Marroquin C, Kuo PC. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 2006;281:18973-82.
DOI
|
12 |
Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 1998;17:1517-25.
DOI
ScienceOn
|
13 |
Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-42.
DOI
ScienceOn
|
14 |
Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Mineral Metab 2000;18:344-9.
DOI
ScienceOn
|
15 |
Raouf A, Seth A. Ets transcription factors and targets in osteogenesis. Oncogene 2000;19:6455-63.
DOI
ScienceOn
|
16 |
Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;8:147-59.
DOI
ScienceOn
|
17 |
Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 1999;274:6972-8.
DOI
|
18 |
Lacorazza HD, Nimer SD. The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis. Blood Cells Mol Dis 2003;31:342-50.
DOI
ScienceOn
|
19 |
Towler DA, Bennett CD, Rodan GA. Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol Endocrinol 1994;8:614-24.
DOI
ScienceOn
|
20 |
Miyazaki Y, Sun X, Uchida H, Zhang J, Nimer S. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene 1996;13:1721-9.
|
21 |
Lu Z, Kim KA, Suico MA, Shuto T, Li JD, Kai H. MEF upregulates human beta-defensin 2 expression in epithelial cells. FEBS Lett 2004;561:117-21.
DOI
|
22 |
Wagner EF, Karsenty G. Genetic control of skeletal development. Curr Opin Genet Dev 2001;11:527-32.
DOI
ScienceOn
|
23 |
Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, et al. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008;13:2001-21.
DOI
|
24 |
Suico MA, Koyanagi T, Ise S, Lu Z, Hisatsune A, Seki Y, et al. Functional dissection of the ETS transcription factor MEF. Biochim Biophys Acta 2002;1577:113-20.
DOI
ScienceOn
|
25 |
Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000;289:1501-4.
DOI
ScienceOn
|